Literature DB >> 31124988

Prevalence of Gastroesophageal Reflux Disease Symptoms in Infants and Children: A Systematic Review.

Maartje Singendonk1, Eline Goudswaard1, Miranda Langendam2, Michiel van Wijk1,3, Faridi van Etten-Jamaludin1, Marc Benninga1, Merit Tabbers1.   

Abstract

OBJECTIVES: Gastroesophageal reflux disease (GERD) is defined as gastroesophageal reflux causing troublesome symptoms or complications. In this study we reviewed the literature regarding the prevalence of GERD symptoms in infants and children.
METHODS: Databases of PubMed, EMBASE, and Cochrane were systematically searched from inception to June 26, 2018. English-written studies based on birth cohort, school-based, or general population samples of ≥50 children aged 0 to 21 years were included. Convenience samples were excluded.
RESULTS: In total, 3581 unique studies were found, of which 25 studies (11 in infants and 14 in children) were included with data on the prevalence of GERD symptoms comprising a total population of 487,969 children. In infants (0-18 months), GERD symptoms are present in more than a quarter of infants on a daily basis and show a steady decline in frequency with almost complete disappearance of symptoms at the age of 12 months. In children older than 18 months, GERD symptoms show large variation in prevalence between studies (range 0%-38% of study population) and overall, are present in >10% and in 25% on respectively a weekly and monthly basis. Of the risk factors assessed, higher body mass index and the use of alcohol and tobacco were associated with higher GERD symptom prevalence.
CONCLUSIONS: This systematic review demonstrates that the reported prevalence of GERD symptoms varies considerably, depending on method of data collection and criteria used to define symptoms. Nevertheless, the high reported prevalence rates support better investment of resources and educational campaigns focused on prevention.

Entities:  

Year:  2019        PMID: 31124988     DOI: 10.1097/MPG.0000000000002280

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  The Spectrum of Reflux Phenotypes.

Authors:  Lisa B Mahoney; Rachel Rosen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-12

2.  Gastro-oesophageal reflux is not a major cause of brief resolved unexplained events in infants.

Authors:  Nadeem Z Jilani; Amna Hussain; Khalid Al Ansari; Colin V E Powell
Journal:  Breathe (Sheff)       Date:  2019-06

Review 3.  A Narrative Review on the Update in the Prevalence of Infantile Colic, Regurgitation, and Constipation in Young Children: Implications of the ROME IV Criteria.

Authors:  Leilani Muhardi; Marion M Aw; Mohammed Hasosah; Ruey Terng Ng; Sze Yee Chong; Badriul Hegar; Erick Toro-Monjaraz; Andy Darma; Merih Cetinkaya; Chung Mo Chow; Urszula Kudla; Yvan Vandenplas
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418

4.  Clinical Practice Guidelines on Pediatric Gastroesophageal Reflux Disease: A Systematic Quality Appraisal of International Guidelines.

Authors:  Jacob Harris; Kevin Chorath; Eesha Balar; Katherine Xu; Anusha Naik; Alvaro Moreira; Karthik Rajasekaran
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-03-10

5.  Concomitant gastrostomy tube insertion during laparoscopic Nissen fundoplication for gastro-esophageal reflux disease: analysis of risk factors for fundoplication failure.

Authors:  Louise Montalva; Aurora Mariani; Françoise Schmitt; Cécile O Muller; Khalid Alzahrani; Jérôme Viala; Alexis Mosca; Matthieu Peycelon; Arnaud Bonnard
Journal:  Surg Endosc       Date:  2020-08-24       Impact factor: 4.584

6.  Efficacy and safety of traditional Chinese herbal formula combined with western medicine for gastroesophageal reflux disease: A protocol for systematic review and meta-analysis.

Authors:  Wuhong Lin; Guihua Huang; Xirong Liu; Huasheng Lin; Heng Zhou; Chunbing Feng; Tingshuai Wang; Renjiu Liang
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.